This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2003 May;10(5):373-80.

doi: 10.1016/s1074-5521(03)00104-2.

Understanding HTLV-I protease

Suzanne Beckham Shuker¹, Victoria L Mariani, Bryan E Herger, Kelly J Dennison

Affiliations

PMID: 12770819
DOI: 10.1016/s1074-5521(03)00104-2

Review

Understanding HTLV-I protease

Suzanne Beckham Shuker et al. Chem Biol. 2003 May.

. 2003 May;10(5):373-80.

doi: 10.1016/s1074-5521(03)00104-2.

Authors

Suzanne Beckham Shuker¹, Victoria L Mariani, Bryan E Herger, Kelly J Dennison

Affiliation

¹ School of Chemistry and Biochemistry, Georgia Institute of Technology, Atlanta, GA 30332, USA. suzy.shuker@chemistry.gatech.edu

PMID: 12770819
DOI: 10.1016/s1074-5521(03)00104-2

No abstract available

PubMed Disclaimer

Similar articles

Narrow substrate specificity and sensitivity toward ligand-binding site mutations of human T-cell Leukemia virus type 1 protease.
Kádas J, Weber IT, Bagossi P, Miklóssy G, Boross P, Oroszlan S, Tözsér J. Kádas J, et al. J Biol Chem. 2004 Jun 25;279(26):27148-57. doi: 10.1074/jbc.M401868200. Epub 2004 Apr 20. J Biol Chem. 2004. PMID: 15102858
Substrates and inhibitors of human T-cell leukemia virus type I protease.
Ding YS, Rich DH, Ikeda RA. Ding YS, et al. Biochemistry. 1998 Dec 15;37(50):17514-8. doi: 10.1021/bi982004a. Biochemistry. 1998. PMID: 9860866
The protease of human T-cell leukemia virus type-1 is a potential therapeutic target.
Tözsér J, Weber IT. Tözsér J, et al. Curr Pharm Des. 2007;13(12):1285-94. doi: 10.2174/138161207780618849. Curr Pharm Des. 2007. PMID: 17504236 Review.
Substrates and inhibitors of human T-cell leukemia virus type 1 (HTLV-1) proteinase.
Hrusková-Heidingsfeldová O, Bláha I, Urban J, Strop P, Pichová I. Hrusková-Heidingsfeldová O, et al. Leukemia. 1997 Apr;11 Suppl 3:45-6. Leukemia. 1997. PMID: 9209292
Design of inhibitors against HIV, HTLV-I, and Plasmodium falciparum aspartic proteases.
Abdel-Rahman HM, Kimura T, Hidaka K, Kiso A, Nezami A, Freire E, Hayashi Y, Kiso Y. Abdel-Rahman HM, et al. Biol Chem. 2004 Nov;385(11):1035-9. doi: 10.1515/BC.2004.134. Biol Chem. 2004. PMID: 15576323 Review.

See all similar articles

Cited by

Viral proteases: Structure, mechanism and inhibition.
Zephyr J, Kurt Yilmaz N, Schiffer CA. Zephyr J, et al. Enzymes. 2021;50:301-333. doi: 10.1016/bs.enz.2021.09.004. Epub 2021 Nov 17. Enzymes. 2021. PMID: 34861941 Free PMC article.
C-terminal residues of mature human T-lymphotropic virus type 1 protease are critical for dimerization and catalytic activity.
Kádas J, Boross P, Weber IT, Bagossi P, Matúz K, Tözsér J. Kádas J, et al. Biochem J. 2008 Dec 15;416(3):357-64. doi: 10.1042/BJ20071132. Biochem J. 2008. PMID: 18636969 Free PMC article.
Different Mutation Tolerance of Lentiviral (HIV-1) and Deltaretroviral (BLV and HTLV) Protease Precursors.
Mótyán JA, Kassay N, Matúz K, Tőzsér J. Mótyán JA, et al. Viruses. 2022 Aug 26;14(9):1888. doi: 10.3390/v14091888. Viruses. 2022. PMID: 36146695 Free PMC article.
Portrait of the Intrinsically Disordered Side of the HTLV-1 Proteome.
Lyngdoh DL, Shukla H, Sonkar A, Anupam R, Tripathi T. Lyngdoh DL, et al. ACS Omega. 2019 Jun 7;4(6):10003-10018. doi: 10.1021/acsomega.9b01017. eCollection 2019 Jun 30. ACS Omega. 2019. PMID: 31460093 Free PMC article.
Design of new potent HTLV-1 protease inhibitors: in silico study.
Kheirabadi M, Maleki J, Soufian S, Hosseini S. Kheirabadi M, et al. Mol Biol Res Commun. 2016 Mar;5(1):19-30. Mol Biol Res Commun. 2016. PMID: 27844017 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Other Literature Sources
- The Lens - Patent Citations Database